Pure Life Healthcare Management Announces Acquisition of Revolution Medical Cannabis Clinic

Pure Life Healthcare Management Announces Acquisition of Revolution Medical Cannabis Clinic

Pure Life Healthcare Management (PLHM), an integrated wrap-around healthcare provider today announced the successful acquisition of Revolution Medical Cannabis (RMC), a prominent virtual clinic specializing in the delivery of medical Cannabis for the Canadian market. This strategic acquisition further solidifies PLHM's commitment to revolutionizing healthcare delivery and expanding its digital footprint in the telehealth sector.

RMC has built an impressive network of doctors providing top-tier virtual care to thousands of patients across the country with its state-of-the-art platform. By integrating RMC's unique offerings, PLHM aims to enhance its current services and provide a more comprehensive and seamless patient experience.

"As we continue our journey to redefine healthcare in the digital age, the acquisition of Revolution represents a significant step with our vision to lead the digital transformation of healthcare. Their expertise and technological capabilities will not only complement our current services but also enable us to reach more patients in innovative ways. Together, we will set new standards for virtual healthcare delivery, ensuring that every patient, no matter where they are, has access to quality care right at their fingertips."

- Doug Page, CEO of PLHM

Integrating the two companies will combine technological resources, streamline virtual consultations, and ensure faster, more reliable access to medical professionals. Existing patients of RMC can expect a smooth transition with continued excellence in care and a host of enhanced features in the near future.

About Pure Life Healthcare Management

Pure Life Healthcare Management is a company dedicated to providing comprehensive support for individuals dealing with trauma, including PTSD. With a specific focus on veterans, first responders, and front-line healthcare workers, PLHM is poised to be the first national network of wrap-around medical facilities focusing on treating trauma. The company adopts a holistic approach that integrates mental, physical, and emotional support, demonstrating a commitment to addressing the various aspects of healing and recovery.

About Revolution Medical Cannabis

Revolution Medical Cannabis was founded with a deep commitment to bridging healthcare gaps and is a pioneering virtual clinic catering to the distinct needs of clients across the country. With an extensive network of top-tier doctors and medical professionals, RMC specializes in delivering timely, efficient, and tailored healthcare solutions. Their reach extends Canada-wide, ensuring not only expert consultations but also doorstep delivery of prescribed medications, embodying our vision of comprehensive and accessible healthcare for all.

For more information, please contact:
Doug Page, CEO
1 888 454 4144

Cautionary Statement About Forward-Looking Information:

This document contains statements that may constitute forward-looking information under applicable securities legislation. Such forward-looking information can often, but not always, be identified by the use of words like "anticipates", "believes", "estimates", "projects", "potential", "plans", "seeks", or statements that events, conditions, or results "will", "may", "could" or "should" occur or be achieved, and other similar expressions. These statements reflect management's current beliefs and are based on information currently available to management. Forward-looking information involves risks, uncertainties, and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking information.

Factors that could cause actual results to differ materially from these forward-looking statements include those risks set out in the Company's public documents filed on national securities websites in the country of incorporation. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this document are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this document, and no assurance can be given that such events will occur. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by applicable law.

Click here to connect with Pure Life Healthcare Management (PLHM) to receive an Investor Presentation


The Conversation (0)
Principal Technologies (TSXV:PTEC)

Principal Technologies Announces New Stock Option Plan

Principal Technologies Inc. (the "Company") (TSXV: PTEC), is pleased to announce that the Board of Directors of the Company (the "Board") has approved the adoption of a new 20% fixed stock option plan (the "New Option Plan").

On July 11, 2023, the Board adopted a 10% fixed stock option plan (the "Considered Plan") (see press release date July 11, 2023). The Considered Plan was subject to approval by the TSX Venture Exchange (the "Exchange") and would be in addition to the Company's 10% rolling stock option plan (the "Option Plan") that was last approved by shareholders at their annual general and special meeting held on November 30, 2022. Upon review and consultation with the Exchange, the Board has subsequently adopted the New Option Plan.

Keep reading...Show less
"Wrap-around Care" Model Helps Address Gaps in Mental Healthcare

"Wrap-around Care" Model Helps Address Gaps in Mental Healthcare

With over 1.3 million Canadians currently struggling with trauma and post-traumatic stress disorder (PTSD), Pure Life Healthcare Management is working to offer a wrap-around care model for better healing, according to CEO Doug Page.

The model allows individuals to walk in and have a single health provider deliver a wide spectrum of support for healing.

“What we’re trying to do is build out both from a telehealth perspective with physical locations where you’re able to walk in and get 20 different services … Some clients might only need two or three services. Some clients are going to be accessing that dozen-plus different services, depending on what their background is,” Page said.

Keep reading...Show less
pills spilling out of a pill bottle on a yellow background

Pharma Stocks: 5 Biggest Companies

The biggest pharmaceutical companies in the world are responsible for developing and manufacturing the vast majority of prescription drugs, giving them a key role in the life science industry.

The pharma sector is responsible for the discovery, development and manufacturing of drugs and medicine. Companies are developing innovative treatments in areas like immuno-oncology and neurology, as well as novel options for rare diseases. 2023 in particular has seen a lot of buzz around diabetes and weight loss treatments.

With the pharmaceutical sector projected to reach a staggering US$1.6 trillion in total revenue by 2028, the need for the industry is great. Opportunities for investment are also sizeable, but what's the best place to start? Those who want exposure to the pharma market may want to begin by looking at the major players in the space.

Keep reading...Show less
Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, announced today that study results demonstrated an experimental model of pericarditis induces mesothelial to mesenchymal transition ("MMT") and that this process is inhibited by cannabidiol treatment, the active pharmaceutical ingredient in CardiolRx™. An abstract summarizing these results was submitted by the Company's international research collaborators from the University of Virginia and Houston Methodist DeBakey Heart & Vascular Center to the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases ("MPD2023") held on November 15 and 16, 2023 in Belgrade, Serbia.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Cardiol Therapeutics

Cardiol Therapeutics

Keep reading...Show less

Jamieson Wellness Inc. Reports Strong Third Quarter 2023 Results

Consolidated revenue growth of 9.1%;
Jamieson Brands revenue grew 15.0% led by increased demand in the U.S. and China

Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX: JWEL) today reported its third quarter results for the period ended September 30, 2023. All amounts are expressed in Canadian dollars.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News